MDG1:FRA
MediGene AG
€0.017
arrow_upward
+3.61%(+0.00060) 1દિ
30 જૂન, 10:00:00 PM GMT+2 · EUR
search
બધા પ્રતીકો
| પ્રતીક | ભાવ | ફેરફાર | ફેરફાર %માં |
|---|
ન્યૂઝ સ્ટોરી
વેબ સૉર્સ અને ન્યૂઝ પાર્ટનર તરફથી
Simply Wall Street
·
21 મિનિટ પહેલાં
Coinbase Stock and 2 Trading Platforms Facing a CFTC Rule Shift
Seeking Alpha
·
1 કલાક પહેલાં
15 Years In, I've Never Seen The S&P 500 Hide So Much Damage
Investing.com
·
17 મિનિટ પહેલાં
Why ’Net Stocks’ are down sharply this year despite Nasdaq’s gains
MarketWatch
·
1 દિવસ પહેલાં
S&P 500 at 10,000 or bust: New ETF offers investors all-or-nothing bet on the index
પ્રોફાઇલ
Medigene AG is a publicly listed biotechnology company headquartered in Martinsried near Munich, Germany. Medigene is working on the development of immunotherapies to enhance T cell activity against solid cancers. The first product candidates are in clinical development. Wikipedia